These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36127970)

  • 1. Guillain-Barré Syndrome: A Sequela of the Original COVID-19 Infection or Vaccination.
    Ilyas U; Umar Z; Bhangal R; Shah D; Fayman B
    Cureus; 2022 Aug; 14(8):e28044. PubMed ID: 36127970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
    Bouattour N; Hdiji O; Sakka S; Fakhfakh E; Moalla K; Daoud S; Farhat N; Damak M; Mhiri C
    Neurol Sci; 2022 Feb; 43(2):755-761. PubMed ID: 34796417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN.
    Tutar NK; Eyigürbüz T; Yildirim Z; Kale N
    Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré Syndrome in an Elderly Patient as a Complication of COVID-19 Infection.
    Miyajan KF; Alyamani NA; Zafer DO; Tawakul AA
    Cureus; 2021 Oct; 13(10):e19154. PubMed ID: 34868787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
    Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
    Front Immunol; 2022; 13():894872. PubMed ID: 35924236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID-19 Guillain-Barré Syndrome: A case report from Oman.
    Al-Zadjali MM; Al Shibli E; Al Maskari M; Gujjar AR; Al Asmi A
    Sultan Qaboos Univ Med J; 2022 Aug; 22(3):409-412. PubMed ID: 36072070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination.
    Carranza O; Babici D; Waheed S; Yousuf F
    Cureus; 2022 Apr; 14(4):e24252. PubMed ID: 35602794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barre Syndrome in a Patient With Asymptomatic Coronavirus Disease 2019 Infection and Major Depressive Disorder.
    Mokhashi N; Narla G; Marchionni C
    Cureus; 2021 Mar; 13(3):e14161. PubMed ID: 33927956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant Guillain-Barre syndrome with COVID-19: a case report.
    Mackenzie N; Lopez-Coronel E; Dau A; Maloof D; Mattar S; Garcia JT; Fontecha B; Lanata CM; Guillen-Burgos HF
    BMC Neurol; 2021 Mar; 21(1):135. PubMed ID: 33757457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course and Treatment of a Rare Neurological Sequelae After COVID-19: Miller Fisher Syndrome.
    Kara S; Wilson MA; Youssef P; Nedd K
    Cureus; 2022 Oct; 14(10):e29977. PubMed ID: 36381748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Immunoglobulin may Reverse Multisystem Inflammation in COVID-19 Pneumonitis and Guillain-Barré Syndrome.
    Chakraborty N; Kumar H
    Indian J Crit Care Med; 2020 Dec; 24(12):1264-1268. PubMed ID: 33446983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Coronavirus (COVID-19)-Associated Guillain-Barre' Syndrome: Case Report.
    Mantefardo B; Gube AA; Awlachew E; Sisay G
    Int Med Case Rep J; 2021; 14():251-253. PubMed ID: 33907474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological Consequences of COVID-19: A Curious Case of Delayed Onset Guillain-Barre.
    Devarakonda AK; Stumpe TR; Saucier AN; Riley T
    Cureus; 2022 May; 14(5):e25325. PubMed ID: 35761907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Guillain-Barré Syndrome With Multiple Causative Factors in a Young Male.
    Zaka A; Dehkordi O; Weir R; Oyawusi M; Millis RM
    Cureus; 2023 Nov; 15(11):e49745. PubMed ID: 38161846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Guillain-Barré syndrome presenting with fluctuating weakness.
    Crowther LL; Randhawa AK; Plambeck RW
    Proc (Bayl Univ Med Cent); 2023; 36(1):111-113. PubMed ID: 36578625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome associated with COVID-19: a case report.
    Gagarkin DA; Dombrowski KE; Thakar KB; DePetrillo JC
    J Med Case Rep; 2021 Apr; 15(1):219. PubMed ID: 33910640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Neuro Physiotherapeutic Reformation in a Teenager Agonizing With Guillain-Barre Syndrome Linked With COVID-19 Infection.
    Harjpal P; Menon S; Kovela RK; Qureshi MI
    Cureus; 2022 Aug; 14(8):e28650. PubMed ID: 36196305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
    Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F
    Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.